Bisoprolol in heart failure
Drummond, G.
Hospital Medicine 61(4): 289
2000
ISSN/ISBN: 1462-3935 PMID: 10858813 Document Number: 523328
Document emailed within 1 workday
Related Documents
Ivanenko, V.V.; Riazantseva, N.V.; Tarasov, D.L.; Lopatin, I.M. 2004: Effect of beta-Blocker Bisoprolol on Function of Hibernating Myocardium in Patients with Chronic Heart Failure of Ischemic Etiology Kardiologiia 44(7): 57-61Ageev, F.T.; Zhubrina, E.S.; Ovchinnikov, A.G.; Seredenina, E.M. 2010: Clinical, hemodynamic and neurohumoral effects of switching patients with chronic heart failure from not recommended -adrenoblockers to bisoprolol in ambulatory practice Kardiologiia 50(6): 41-47
Belenkov, I.N.; Skvortsov, A.A.; Mareev, V.I.; Nasonova, S.N.; Sychev, A.V.; Narusov, O.I.; Baklanova, N.A.; Masenko, V.P. 2003: Clinical, hemodynamic and neurohumoral effects of long-term therapy of patients with severe chronic heart failure with beta-adrenoblocker bisoprolol Kardiologiia 43(10): 10-21
Widimsky, J. 1975: Heart failure. Pathogenesis of heart failure and diagnosis of the incipient stage of heart failure Cor et Vasa 17(4): 302-314
1997: Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group Lancet 349(9049): 375-380
Feenstra, J.; Heerdink, E.R.; Grobbee, D.E.; Stricker, B.H.Ch. 2002: Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study Archives of Internal Medicine 162(3): 265-270
Takahashi, H. 2007: Pathophysiology of heart failure and the biomarkers; brain natriuretic hormone as the class-1 recommendation by the new Japanese Guideline for Heart Failure Rinsho Byori. Japanese Journal of Clinical Pathology 55(12): 1088-1096
Landström, N.; Kesek, M.; Jensen, S.M. 2013: Too few patients get heart failure pacemakers. it can provide better treatment in heart failure and left bundle branch block Lakartidningen 110(5): 216-219
Kanoksilp, A.; Hengrussamee, K.; Wuthiwaropas, P. 2009: A comparison of one-year outcome in adult patients with heart failure in two medical setting: heart failure clinic and daily physician practice Journal of the Medical Association of Thailand 92(4): 466-470
Correia, J.; Silva, Fátima.Franco.; Roque, C.; Vieira, H.; Providéncia, Lís.Augusto. 2007: Impact of a specialized outpatient heart failure follow-up program on hospitalization frequency and functional status of patients with advanced heart failure Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 26(4): 335-343
Gomberg-Maitland, M.; Baran, D.A.; Fuster, V. 2001: Treatment of congestive heart failure: guidelines for the primary care physician and the heart failure specialist Archives of Internal Medicine 161(3): 342-352
Kuch, M.; Janiszewski, M.; Janiszewski, M.ł; Braksator, W.; Mamcarz, A.; Sadkowska, K.; Kuch, J.; Dłuzniewski, M.ła. 2006: Prognostic value of symptoms and signs of advanced heart failure and low left ventricle ejection fraction in patients after myocardial infarction with chronic heart failure Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 20(117): 285-288
Ahmed, A. 2009: DEFEAT - Heart Failure: a guide to management of geriatric heart failure by generalist physicians Minerva Medica 100(1): 39-50
Guimarães, A.C. 1993: Congestive heart failure. Concept of diastolic and systolic heart failure. A didactic presentation Arquivos Brasileiros de Cardiologia 60(1): 13-14
Komajda, M. 1999: Neurohormonal mechanisms in congestive heart failure with special reference to diastolic heart failure Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 18 Suppl. 5: V93-V96
O'Connell, J.B.; Cobb, A.B. 1996: Heart failure evaluation and treatment in Mississippi: results from a survey of the Mississippi Foundation for Medical Care. Heart Failure Study Group Journal of the Mississippi State Medical Association 37(7): 648-652
Azuma, J. 1994: Long-term effect of taurine in congestive heart failure: preliminary report. Heart Failure Research with Taurine Group Advances in Experimental Medicine and Biology 359: 425-433
Tarantini, L.; Cioffi, G.; Opasich, C.; Di Lenarda, A.; Pulignano, G.; Del Sindaco, D.; De Feo, S.; Stefenelli, C.; Russo, P.; Catania, G. 2004: Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 5(6): 441-449
Nony, P.; Boissel, J.P.; Girard, P.; Leizorovicz, A.; Lievre, M.; Chifflet, R. 1992: Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure European Heart Journal 13(8): 1101-1108
Amosov, N.M.; Knyshov, G.V.; Mintser, O.P.; Ugarov, B.N.; Kononenko, I.N. 1982: Dynamics of cardiac minute volume in the diagnosis of heart failure in acquired heart defects and ischemic heart disease in the postoperative period Kardiologiia 22(10): 21-23